Disease Markers / 2015 / Article / Tab 1

Research Article

Validation of Serum Biomarkers Derived from Proteomic Analysis for the Early Screening of Preeclampsia

Table 1

Maternal and neonatal characteristics of cases and controls included in the study [17].

Controls ( = 48)PE ( = 24)Statistics

Maternal age (y)32.2
28.8–37.3
32.9
27.3–35.0
NS
Prepregnancy BMI (kg/m2)24.8
22.5–26.2
27.9
23.4–32.9
= .000
Cigarette smoker35 (73%)12 (50%) = .028
Nulliparous29 (60.4%)22 (91.6%) = .013
Parous19 (39.6%)2 (8.4%)
Family history of PE00
Conception
 Spontaneous42 (87.5%)24 (100%) = .090
 IVF6 (12.5%)0
Medical history
 Diabetes mellitus00
 Thrombophilia01
Mode of delivery
 Vaginal birth ()33 (68.7%)8 (33.3%) = .013
 Caesarean delivery ()15 (31.3%)16 (66.6%)
Gestational age at delivery (wk)40.2
37.2–42.0
38.1
32.1–40.6
 <37 wk ()07 = .000
 <34 wk ()02
Birth weight (g)3410
2880–4250
2780
980–3950
 >10th percentile ()4811 = .020
 <10th percentile ()011
 <5th percentile ()02